Sindhwani R, Bora K, Hazra S
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39680103
DOI: 10.1007/s00210-024-03713-4.
Do D, Lee T, Santana C, Inneh A, Patel U
Am J Prev Cardiol. 2024; 20:100887.
PMID: 39583639
PMC: 11582466.
DOI: 10.1016/j.ajpc.2024.100887.
Subhadra M, Mir D, Ankita K, Sindunathy M, Kishore H, Ravichandiran V
Front Endocrinol (Lausanne). 2024; 15:1383520.
PMID: 39539936
PMC: 11557309.
DOI: 10.3389/fendo.2024.1383520.
Ferrario C, Munzberg-Gruening H, Rinaman L, Betley J, Borgland S, Dus M
Obesity (Silver Spring). 2024; 32(8):1425-1440.
PMID: 39010249
PMC: 11269035.
DOI: 10.1002/oby.24060.
Alemany M
Int J Mol Sci. 2024; 25(4).
PMID: 38396928
PMC: 10888680.
DOI: 10.3390/ijms25042251.
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.
Erzen S, Tonin G, Jurisic Erzen D, Klen J
Int J Mol Sci. 2024; 25(3).
PMID: 38338796
PMC: 10855385.
DOI: 10.3390/ijms25031517.
The impact of obesity on different glucose tolerance status with incident cardiovascular disease and mortality events over 15 years of follow-up: a pooled cohort analysis.
Asgari S, Molavizadeh D, Soltani K, Khalili D, Azizi F, Hadaegh F
Diabetol Metab Syndr. 2024; 16(1):27.
PMID: 38267963
PMC: 10809520.
DOI: 10.1186/s13098-023-01253-0.
In Silico identification of novel phytochemicals that target SFRP4: An early biomarker of diabesity.
Rehman A, Bukhari S, Akhter N, Ijaz Hussain M, Chauhdary Z
PLoS One. 2023; 18(11):e0292155.
PMID: 37943820
PMC: 10635506.
DOI: 10.1371/journal.pone.0292155.
Single anastomosis duodeno-ileal bypass with sleeve gastrectomy generates sustained improvement of glycemic control compared with sleeve gastrectomy in the diet-induced obese rat model.
Becerril S, Cienfuegos J, Rodriguez A, Catalan V, Ramirez B, Valenti V
J Physiol Biochem. 2023; 80(1):149-160.
PMID: 37935948
PMC: 10810039.
DOI: 10.1007/s13105-023-00993-x.
Reactive oxygen species: role in obesity and mitochondrial energy efficiency.
Corkey B
Philos Trans R Soc Lond B Biol Sci. 2023; 378(1885):20220210.
PMID: 37482778
PMC: 10363708.
DOI: 10.1098/rstb.2022.0210.
Automated body composition estimation from device-agnostic 3D optical scans in pediatric populations.
Tian I, Wong M, Nguyen W, Kennedy S, McCarthy C, Kelly N
Clin Nutr. 2023; 42(9):1619-1630.
PMID: 37481870
PMC: 10528749.
DOI: 10.1016/j.clnu.2023.07.012.
Five blueberry anthocyanins and their antioxidant, hypoglycemic, and hypolipidemic effects .
Zhu C, Lu H, Du L, Li J, Chen H, Zhao H
Front Nutr. 2023; 10:1172982.
PMID: 37275633
PMC: 10232738.
DOI: 10.3389/fnut.2023.1172982.
Management of diabesity: Current concepts.
Michaelidou M, Pappachan J, Jeeyavudeen M
World J Diabetes. 2023; 14(4):396-411.
PMID: 37122433
PMC: 10130896.
DOI: 10.4239/wjd.v14.i4.396.
Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis.
Hu S, Lin C, Cai X, Li Z, Lv F, Yang W
EClinicalMedicine. 2023; 57:101868.
PMID: 36864984
PMC: 9971277.
DOI: 10.1016/j.eclinm.2023.101868.
Efficacy of the holistic, psychonutritional approach of in the management of type 2 diabetes among patients with obesity and dysfunctional eating.
Barana L, Colleluori G, Sulpizi M, Ortenzi K, Farano L, Fanelli C
J Diabetes Metab Disord. 2022; 21(2):1883-1893.
PMID: 35891980
PMC: 9305049.
DOI: 10.1007/s40200-022-01085-1.
United States Dietary Trends Since 1800: Lack of Association Between Saturated Fatty Acid Consumption and Non-communicable Diseases.
Lee J, Duster M, Roberts T, Devinsky O
Front Nutr. 2022; 8:748847.
PMID: 35118102
PMC: 8805510.
DOI: 10.3389/fnut.2021.748847.
Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review).
Tilinca M, Tiuca R, Niculas C, Varga A, Tilea I
Exp Ther Med. 2021; 22(4):1167.
PMID: 34504612
PMC: 8394024.
DOI: 10.3892/etm.2021.10601.
A 2021 Update on the Use of Liraglutide in the Modern Treatment of 'Diabesity': A Narrative Review.
Tilinca M, Tiuca R, Burlacu A, Varga A
Medicina (Kaunas). 2021; 57(7).
PMID: 34209532
PMC: 8307742.
DOI: 10.3390/medicina57070669.
Deficient Leptin Cellular Signaling Plays a Key Role in Brain Ultrastructural Remodeling in Obesity and Type 2 Diabetes Mellitus.
Hayden M, Banks W
Int J Mol Sci. 2021; 22(11).
PMID: 34063911
PMC: 8196569.
DOI: 10.3390/ijms22115427.
Are caveolin-1 minor alleles more likely to be risk alleles in insulin resistance mechanisms in metabolic diseases?.
Abaj F, Saeedy S, Mirzaei K
BMC Res Notes. 2021; 14(1):185.
PMID: 34001235
PMC: 8130340.
DOI: 10.1186/s13104-021-05597-6.
